MacDonald Kelly
Insider CIK 1781117 · DVAX SVP and CFO · IRWD Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 350,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 90,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 65,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 70,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 15,476 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 28,283 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 100,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 46,430 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 42,424 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2026-02-10 | 2026-02-10 | 42,424 | — | $0 | 42,424 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2026-02-10 | 2026-02-10 | 46,430 | — | $0 | 46,430 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | U Tender | 2026-02-10 | 2026-02-10 | 60,204 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-12-24 | 2025-12-29 | 36,141 | $15.38 | $555.8K | 60,204 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-12-23 | 2025-12-29 | 15,477 | — | $0 | 15,477 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-12-23 | 2025-12-29 | 14,141 | — | $0 | 28,282 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-12-23 | 2025-12-29 | 15,477 | — | $0 | 82,204 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2025-12-23 | 2025-12-29 | 37,500 | — | $0 | 66,727 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-12-23 | 2025-12-29 | 14,141 | — | $0 | 96,345 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-18 | 2025-02-20 | 15,477 | — | $0 | 30,953 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-18 | 2025-02-20 | 4,975 | $12.93 | $64.3K | 29,227 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-18 | 2025-02-20 | 15,477 | — | $0 | 34,202 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 42,424 | — | $0 | 42,424 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 70,000 | — | $0 | 70,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-13 | 2025-02-18 | 16,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-13 | 2025-02-18 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-13 | 2025-02-18 | 16,000 | — | $0 | 24,043 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-13 | 2025-02-18 | 5,318 | $12.69 | $67.5K | 18,725 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2025-02-10 | 2025-02-12 | 5,333 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2025-02-10 | 2025-02-12 | 1,997 | $13.20 | $26.4K | 8,043 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2025-02-10 | 2025-02-12 | 5,333 | — | $0 | 10,040 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-02-15 | 2024-02-20 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-02-15 | 2024-02-20 | 46,430 | — | $0 | 46,430 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2024-02-12 | 2024-02-13 | 2,985 | $12.82 | $38.3K | 4,707 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2024-02-10 | 2024-02-13 | 5,333 | — | $0 | 5,333 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2024-02-10 | 2024-02-13 | 5,333 | — | $0 | 7,692 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise deriv | 2023-02-27 | 2023-03-01 | 5,334 | — | $0 | 10,666 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | F Tax w/h | 2023-02-27 | 2023-03-01 | 2,975 | $10.36 | $30.8K | 2,359 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 5,334 | — | $0 | 5,334 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2023-02-16 | 2023-02-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-02-10 | 2022-02-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-02-10 | 2022-02-14 | 90,500 | — | $0 | 90,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-03-01 | 2021-03-02 | 350,000 | — | $0 | 350,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise deriv | 2020-12-04 | 2020-12-08 | 5,639 | — | $0 | 0 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise | 2020-12-04 | 2020-12-08 | 5,639 | $9.12 | $51.4K | 98,680 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-12-04 | 2020-12-08 | 5,639 | $12.50 | $70.5K | 93,041 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise deriv | 2020-11-11 | 2020-11-13 | 3,561 | — | $0 | 0 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-11-11 | 2020-11-13 | 3,561 | $11.75 | $41.8K | 93,041 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | M Exercise | 2020-11-11 | 2020-11-13 | 3,561 | $9.31 | $33.2K | 96,602 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-11-09 | 2020-11-10 | 825 | $10.92 | $9.0K | 93,141 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-11-09 | 2020-11-10 | 100 | $10.92 | $1.1K | 93,041 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-11-06 | 2020-11-10 | 1,872 | $11.25 | $21.1K | 93,966 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-10-08 | 2020-10-13 | 22,714 | $10.50 | $238.5K | 95,838 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-08-17 | 2020-08-19 | 575 | $10.14 | $5.8K | 118,552 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-05-11 | 2020-05-13 | 595 | $10.35 | $6.2K | 118,147 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-05-11 | 2020-05-13 | 558 | $10.35 | $5.8K | 118,742 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2020-02-27 | 2020-03-02 | 36,173 | — | $0 | 119,300 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 303 | $11.63 | $3.5K | 85,918 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 504 | $11.63 | $5.9K | 86,221 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 793 | $11.63 | $9.2K | 85,125 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 303 | $11.63 | $3.5K | 84,822 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 1,695 | $11.63 | $19.7K | 83,127 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2020-02-21 | 2020-02-25 | 302 | $11.63 | $3.5K | 86,725 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2019-12-16 | 2019-12-18 | 8,230 | — | $0 | 86,567 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2019-11-08 | 2019-11-12 | 107 | $11.00 | $1.2K | 78,337 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | S Sale | 2019-11-08 | 2019-11-12 | 880 | $11.00 | $9.7K | 78,444 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2019-07-09 | 2019-07-11 | 7,500 | — | $0 | 79,324 | SEC↗ |